Shares of Supernus Pharmaceuticals, Inc. SUPN surged 14.6% after the company reported that its experimental drug for attention deficit hyperactivity disorder met the main goal of a late-stage study in adults.Palantir Technologies Inc.’s PLTR shares rose 2.3% after the company announced that it has signed a new two-year contract with the U.K.’s National Health Service.Shares of Jaguar Health, Inc. JAGX jumped more than 100% after the company reported that it has signed an agreement for a $6 million sale of royalty interest in Mytesi royalties.Sorrento Therapeutics, Inc.’s SRNE shares surged 18.6% after the company submitted Emergency Use Authorization Application to FDA for its COVI-STIX rapid diagnostic test for the detection of the SARS-CoV-2 virus nucleocapsid antigen. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Supernus Pharmaceuticals, Inc. (SUPN): Free Stock Analysis Report Jaguar Animal Health, Inc. (JAGX): Free Stock Analysis Report Sorrento Therapeutics, Inc. (SRNE): Free Stock Analysis Report Palantir Technologies Inc. (PLTR): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research